A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AEROVANC FOR THE TREATMENT OF PERSISTANT METHICILLIN-RESISTANT Staphylococcus aureus LUNG INFECTION IN CYSTIC FIBROSIS PATIENTS; SAV005-04

Study Overview
TBD
- Study Identifier: 828169
Recruitment Status
OpenContact the research team to learn more about this study.
Fields marked with asterisk (*) are required